Your browser doesn't support javascript.
loading
Genome-wide association analyses of symptom severity among clozapine-treated patients with schizophrenia spectrum disorders.
Okhuijsen-Pfeifer, C; van der Horst, M Z; Bousman, C A; Lin, B; van Eijk, K R; Ripke, S; Ayhan, Y; Babaoglu, M O; Bak, M; Alink, W; van Beek, H; Beld, E; Bouhuis, A; Edlinger, M; Erdogan, I M; Ertugrul, A; Yoca, G; Everall, I P; Görlitz, T; Grootens, K P; Gutwinski, S; Hallikainen, T; Jeger-Land, E; de Koning, M; Lähteenvuo, M; Legge, S E; Leucht, S; Morgenroth, C; Müderrisoglu, A; Narang, A; Pantelis, C; Pardiñas, A F; Oviedo-Salcedo, T; Schneider-Thoma, J; Schreiter, S; Repo-Tiihonen, E; Tuppurainen, H; Veereschild, M; Veerman, S; de Vos, M; Wagner, E; Cohen, D; Bogers, J P A M; Walters, J T R; Yagcioglu, A E Anil; Tiihonen, J; Hasan, A; Luykx, J J.
Afiliación
  • Okhuijsen-Pfeifer C; Department of Psychiatry, University Medical Center Utrecht, Utrecht University, Brain Center, Utrecht, The Netherlands.
  • van der Horst MZ; Department of Translational Neuroscience, University Medical Center Utrecht, Utrecht University, Brain Center, Utrecht, The Netherlands.
  • Bousman CA; Department of Psychiatry, University Medical Center Utrecht, Utrecht University, Brain Center, Utrecht, The Netherlands.
  • Lin B; Department of Translational Neuroscience, University Medical Center Utrecht, Utrecht University, Brain Center, Utrecht, The Netherlands.
  • van Eijk KR; GGNet Mental Health, Warnsveld, The Netherlands.
  • Ripke S; Department of Medical Genetics, University of Calgary, Calgary, Canada.
  • Ayhan Y; Department of Psychiatry, University of Calgary, Calgary, Canada.
  • Babaoglu MO; Department of Physiology & Pharmacology, University of Calgary, Calgary, Canada.
  • Bak M; Department of Psychiatry, University of Melbourne, Melbourne Neuropsychiatry Centre, Melbourne, Australia.
  • Alink W; Department of Psychiatry, University Medical Center Utrecht, Utrecht University, Brain Center, Utrecht, The Netherlands.
  • van Beek H; Department of Translational Neuroscience, University Medical Center Utrecht, Utrecht University, Brain Center, Utrecht, The Netherlands.
  • Beld E; Department of Translational Neuroscience, University Medical Center Utrecht, Utrecht University, Brain Center, Utrecht, The Netherlands.
  • Bouhuis A; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Psychiatry and Psychotherapy, Berlin, Germany.
  • Edlinger M; Department of Psychiatry, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
  • Erdogan IM; Department of Pharmacology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
  • Ertugrul A; Department of Psychiatry and Neuropsychology, Maastricht University, Maastricht, The Netherlands.
  • Yoca G; Mondriaan, Mental Health Institute, Maastricht, The Netherlands.
  • Everall IP; Multicomplexe Zorg, Pro Persona, Wolfheze, The Netherlands.
  • Görlitz T; Clinical Recovery Clinic, Mental Health Services Rivierduinen, Leiden, The Netherlands.
  • Grootens KP; Program for early psychosis & severe mental illness, Pro Persona Mental Healthcare, Wolfheze, The Netherlands.
  • Gutwinski S; Department of Psychiatry, Psychotherapy and Psychosomatics, Division for Psychiatry I, Medical University Innsbruck, Innsbruck, Austria.
  • Hallikainen T; Department of Psychiatry, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
  • Jeger-Land E; Department of Psychiatry, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
  • de Koning M; Department of Psychiatry, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
  • Lähteenvuo M; Sarkisla State Hospital, Ministry of Health, Sivas, Turkey.
  • Legge SE; Department of Psychiatry, University of Melbourne, Melbourne Neuropsychiatry Centre, Melbourne, Australia.
  • Leucht S; Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
  • Morgenroth C; Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany.
  • Müderrisoglu A; Department of Psychiatry, Psychotherapy and Psychosomatics, Medical Faculty University Augsburg, Bezirkskrankenhaus Augsburg, Augsburg, Germany.
  • Pantelis C; Reinier van Arkel, s-Hertogenbosch, The Netherlands.
  • Pardiñas AF; Unit for Clinical Psychopharmacology and Neuropsychiatry, Radboud University Medical Centre, Nijmegen, The Netherlands.
  • Oviedo-Salcedo T; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Psychiatry and Psychotherapy, Berlin, Germany.
  • Schneider-Thoma J; Department of Forensic Psychiatry, University of Kuopio, Niuvanniemi Hospital, Kuopio, Finland.
  • Schreiter S; Arkin, Institute for Mental Health, Amsterdam, The Netherlands.
  • Repo-Tiihonen E; Arkin, Institute for Mental Health, Amsterdam, The Netherlands.
  • Tuppurainen H; Amsterdam UMC, University of Amsterdam, Department of Psychiatry, Amsterdam, The Netherlands.
  • Veereschild M; Department of Forensic Psychiatry, University of Kuopio, Niuvanniemi Hospital, Kuopio, Finland.
  • Veerman S; Division of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, School of Medicine, Cardiff University, Cardiff, United Kingdom.
  • de Vos M; Department of Psychiatry and Psychotherapy, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
  • Wagner E; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Psychiatry and Psychotherapy, Berlin, Germany.
  • Cohen D; Department of Pharmacology, Faculty of Medicine, Kirikkale University, Kirikkale, Turkey.
  • Bogers JPAM; Department of Medical Genetics, University of Calgary, Calgary, Canada.
  • Walters JTR; Department of Psychiatry, University of Melbourne, Melbourne Neuropsychiatry Centre, Melbourne, Australia.
  • Yagcioglu AEA; Division of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, School of Medicine, Cardiff University, Cardiff, United Kingdom.
  • Tiihonen J; Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany.
  • Hasan A; Department of Psychiatry and Psychotherapy, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
  • Luykx JJ; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Psychiatry and Psychotherapy, Berlin, Germany.
Transl Psychiatry ; 12(1): 145, 2022 04 07.
Article en En | MEDLINE | ID: mdl-35393395
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Esquizofrenia / Antipsicóticos / Clozapina / Citocromo P-450 CYP2C19 Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Transl Psychiatry Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Esquizofrenia / Antipsicóticos / Clozapina / Citocromo P-450 CYP2C19 Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Transl Psychiatry Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos